COUGH

This study tested a non-invasive radiofrequency treatment to help people with ongoing breathing issues after COVID-19. 96 adults who had COVID-19 and still had cough, shortness of breath, or fatigue for over a month took part. The treatment uses gentle radio waves to stimulate ti…

This study tested two different ways of taking Robitussin cough syrup in 244 adults with coughs from the common cold. One group used a single syrup for day and night, while the other used separate day and night formulas. The main goal was to see how each approach affected symptom…

This study tested whether a herbal medicine called Reconyl can safely relieve acute cough. 144 adults with sudden cough took either Reconyl or a placebo three times daily for 7 days. The main goal was to see if cough severity improved, measured by a standard scale. The trial is c…

This study tested an experimental drug called orvepitant to see if it could reduce chronic coughing in people with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. About 80 adults with IPF and a persistent cough that didn't respond to other treatments took part. Part…

This study tested whether injecting a nerve-numbing medication near the throat could reduce chronic cough symptoms. Seventeen adults with nerve-related chronic cough received either four real nerve-block injections or four placebo (saltwater) injections. Researchers tracked cough…

This study looked at 502 adults with chronic cough to see if three simple tests (FeNO, blood eosinophils, and total IgE) can predict who will respond to inhaled corticosteroids. Participants took the steroid treatment for 4 weeks, and researchers measured changes in cough severit…

This study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with respiratory conditions like COPD, asthma, and COVID-19. Researchers compared the app's cough counts to patients' own reports and to human listeners. The goal was t…

This study looked at how the drug camlipixant, being tested for chronic cough, behaves in people with liver impairment compared to those with healthy livers. It involved 32 adults aged 18-75. The goal was to understand safety and drug levels, not to treat the cough itself.